Top

Category: Mergers and Acquisitions


Mergers and Acquisitions

Thermo Fisher Scientific Announces Founding Sponsorship of Momentum Labs

February 6, 2023

Via: Biopharm International

Thermo Fisher Scientific recently announced that it had become a founding sponsor of Momentum Labs, a collaborative laboratory and office space to be located in Alachua, Fla. The venture, spearheaded by Gainesville real estate development firm Concept Companies, is designed […]


Clinical Trials, Mergers and Acquisitions, Research and Development

Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials

February 3, 2023

Via: Pharma Times

Aardex Group – a company focused on remote research and healthcare adherence – and Cambridge Cognition have firmed a partnership up to provide monitoring during hybrid and decentralised clinical trials (DCTs). The link-up will involve the incorporation of Aardex’s MEMS […]


Cell and Gene Therapy, Industry, Mergers and Acquisitions

Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss

February 1, 2023

Via: Contract Pharma

Andelyn Biosciences, a gene therapy contract development and manufacturing organization (CDMO), has partnered with Odylia Therapeutics, a nonprofit 501(c)(3) biotech focused on accelerating rare disease drug development, to manufacture a novel gene therapy (OT-004) to treat vision loss caused by […]


Mergers and Acquisitions

Roche, Boehringer tap biosensor firms for patient studies

January 26, 2023

Via: Pharmaphorum

Roche’s alliance with France’s Sysnav Healthcare is in the area of movement disorders, and will build on the tech company’s wearable magneto-inertial sensor device for 3D movement tracking, which has already been accepted as a digital endpoint for use in […]


Mergers and Acquisitions

Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options

January 25, 2023

Via: Contract Pharma

Stevanato Group S.p.A., a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, has entered a collaboration with Transcoject GmbH, a medical device and pharma packaging solutions company. The collaboration will enable Stevanato […]


Mergers and Acquisitions

Sanofi, CytoReason expand AI deal into IBD

January 24, 2023

Via: Pharmaphorum

The partnership between Sanofi and CytoReason – for an undisclosed, multimillion dollar amount – forms part of an ongoing collaboration begun in 2021, which originally focused on obtaining advanced mechanistic insights for asthma endotypes. The collaboration takes CytoReason’s partnering with […]


Mergers and Acquisitions

Syner-G BioPharma Acquires RMC Pharma Solutions

January 23, 2023

Via: Contract Pharma

Syner-G BioPharma Group, a provider of pharmaceutical science and regulatory consulting services, has acquired RMC Pharmaceutical Solutions (RMC). RMC supports the outsourced CMC and Quality needs of biotech and pharma companies across multiple therapeutic areas. Financial terms were not disclosed. […]


Mergers and Acquisitions

Charles River & Rznomics Partner to Initiate Clinical Development of RZ-001

January 20, 2023

Via: Contract Pharma

Charles River Laboratories International Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, have announced a viral vector contract development and manufacturing organization (CDMO) partnership. Rznomics will leverage Charles River’s viral vector […]


Mergers and Acquisitions

Sun Pharma to Acquire Concert Pharmaceuticals for $576M Upfront

January 19, 2023

Via: Contract Pharma

Sun Pharmaceutical Industries and Concert Pharmaceuticals, Inc. entered a definitive agreement under which Sun Pharma will acquire Concert through an upfront payment of $576 million. Concert stockholders will also receive up to an additional $3.50 per share of common stock […]


Industry, Mergers and Acquisitions, Vaccines

Vaxxas announces CEPI partnership to advance needle-free mRNA vaccine patches

January 19, 2023

Via: Pharmaphorum

CEPI is a partnership between public, private, philanthropic, and civil organisations to develop vaccines against future epidemics and pandemics. The agreement, worth $4.3 million, is the first to be announced as part of CEPI’s call in January 2022 for proposals […]


Mergers and Acquisitions

AbbVie and Anima Biotech Partner on Discovery and Development of mRNA Biology Modulators

January 18, 2023

Via: Biopharm International

AbbVie and US-based Anima Biotech (Anima) have formed a collaboration to discover and develop messenger RNA (mRNA) biology modulators for three targets across oncology and immunology. In the collaboration, Anima will use its mRNA Lightning technology platform to discover novel […]


Mergers and Acquisitions

Bayer snaps up digital imaging partner Blackford

January 18, 2023

Via: Pharmaphorum

The takeover comes a few months after Bayer stepped up the digital capabilities of its radiology business with the launch of AI-powered software for X-ray, MRI, and CT imaging under the Calantic Digital Solutions umbrella brand. The launch of Calantic […]


Mergers and Acquisitions

Leap Therapeutics to buy Flame Biosciences in all-stock deal

January 17, 2023

Via: Biopharma Dive

Antibodies targeting the protein Claudin18.2, as Flame’s FL-301 does, have been the focus of some biotechnology dealmaking over the past year, involving companies like Turning Point Therapeutics, Elevation Oncology and even AstraZeneca. Claudin18.2 is expressed in gastrointestinal and pancreatic cancers, […]


Mergers and Acquisitions

Angion stock falls after agreeing Elicio Therapeutics merger

January 17, 2023

Via: Pharmaphorum

Shares in the company fell sharply this morning after the announcement of the deal, which will see the two companies combine behind lead programme ELI-002, an immunotherapy targeting KRAS-driven cancers that is currently in a phase 1 trial in pancreatic […]


Mergers and Acquisitions

Alora Pharmaceuticals Acquires Monarch Manufacturing Facility

January 13, 2023

Via: Contract Pharma

Alora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM’s manufacturing capabilities located in Fort Worth, TX. The acquisition, which closed on January 4, 2022, included all of Monarch’s equipment […]


Mergers and Acquisitions

AbbVie and Anima Biotech collaborate on mRNA biology modulators

January 11, 2023

Via: PMLiVE

The partners will use Anima’s mRNA Lightning platform to discover novel mRNA biology modulators for the collaboration targets, with AbbVie gaining exclusive rights to licence, further develop and commercialise the resulting programmes. In exchange, an upfront payment of $42m will […]


Mergers and Acquisitions

BioNTech buys UK-based AI startup InstaDeep in £562m deal

January 10, 2023

Via: Pharmaphorum

The deal, billed as BioNTech’s largest to date and unveiled at the JP Morgan healthcare conference today, includes $362 million upfront with another £200 million on offer if performance targets are met. The two companies have already been working together […]


Mergers and Acquisitions

Chiesi expands rare disease portfolio with Amryt Pharma acquisition

January 9, 2023

Via: Pharmaphorum

Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 billion, with upfront consideration of $1.25 billion representing a 107% premium […]


Mergers and Acquisitions

Acquisitive Ipsen builds again with $952m Albireo buy

January 9, 2023

Via: Pharmaphorum

The agreement values Boston-based Albireo at $952 million, with shareholders in the company also in line for another $10-per-share payout in a contingent value right (CVR) if Bylvay (odevixibat) gets approved for a follow-up indication. Albireo secured approval in the […]


Mergers and Acquisitions

UK partners with BioNTech on clinical trials of mRNA cancer therapies

January 6, 2023

Via: Pharmaphorum

The cancer immunotherapies will mainly be provided in the context of clinical trials over the alliance, which extends out to 2030, but also covers supply of commercial therapies if approved in the interim. It will also cover some infectious disease […]